A Velumani is not the most popular figure in India’s healthcare sector. When he set up his company, Thyrocare, in 1996 in Mumbai, he disrupted India’s $9 billion diagnostics industry, cutting pricing across tests. As a result, he has routinely faced accusations of his tests being substandard, false or untrustworthy, with doctors across India refusing Thyrocare results and asking patients to re-test at other labs before giving their diagnosis. Being a disruptor in any industry comes at a price.
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Already a premium subscriber? LOGIN NOW
What you get on Business Standard Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- 26 years of website archives.
- Preferential invites to Business Standard events.
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Fri, May 14 2021. 23:20 IST